Clinical Trial: Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Low-Grade Gliomas in Adults
Study Status: Completed
Recruit Status: RECRUITING
Condition: Gliomas
Study Type: INTERVENTIONAL
Official Title: Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Low-Grade Gliomas in Adults
Brief Summary:
To learn if the study drug, ulixertinib, can cross over the blood-brain barrier in patients with recurrent brain tumors
Read more